"Greece Pharmaceuticals & Healthcare Report Q1 2013" Published
BMI View: The Greek pharmaceutical market has been characterised of late by mandated price reductions, state intervention in the trade of pharmaceutical goods, regressive revenue taxes, unpaid debts and drug shortages. Moreover, the Greek government has increasingly shifted some of the burden of healthcare spending onto its citizens, requiring co-payments for expensive drugs.
View full press release